SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-16-000665
Filing Date
2016-07-13
Accepted
2016-07-13 13:06:18
Documents
1
Period of Report
2016-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 29326
  Complete submission text file 0001192482-16-000665.txt   30680
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Issuer) CIK: 0001327467 (see all company filings)

IRS No.: 202680869 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O QUAKER BIOVENTURES, CIRA CENTRE 2929 ARCH STREET, 3RD FLOOR PHILADELPHIA PA 19104-2868
Business Address
Kollender Richard S (Reporting) CIK: 0001415666 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 161765314